AstaReal Astaxanthin (Haematococcus pluvialis)
AstaReal Astaxanthin is a potent carotenoid antioxidant derived from Haematococcus pluvialis microalgae. It reduces oxidative stress by neutralizing free radicals and modulating inflammatory pathways through NF-κB inhibition.

Origin & History
AstaReal Astaxanthin is a xanthophyll carotenoid derived from the microalga Haematococcus pluvialis, a freshwater green algae that produces astaxanthin as a protective pigment under stress conditions. The compound is extracted from cultivated algae through proprietary methods that concentrate this natural red-orange pigment, characterized by its unique molecular structure containing multiple conjugated double bonds and ionone rings.
Historical & Cultural Context
The research dossier does not provide information on traditional or historical use of astaxanthin or Haematococcus pluvialis. Modern commercial cultivation and extraction methods have made this potent antioxidant available as a dietary supplement relatively recently.
Health Benefits
• Reduces oxidative stress markers: Meta-analysis of 7 RCTs (n=188) showed significant reduction in advanced oxidation protein products (SMD = -1.06) and another meta-analysis of 12 RCTs (n=380) found reduced malondialdehyde levels • Improves rheumatoid arthritis symptoms: RCT (n=60) demonstrated significant reductions in Disease Activity Score 28, Health Assessment Questionnaire scores, and ESR with 20 mg/day for 8 weeks • Supports metabolic health in diabetes: RCT (n=44) showed improved MDA and IL-6 levels in T2DM patients with 8 mg/day for 8 weeks • Enhances skin health: Clinical trials demonstrate improvements in skin texture, wrinkle appearance, and moisture content • Boosts exercise performance: Systematic review concluded significant enhancement of aerobic exercise efficiency, particularly at higher doses and longer durations
How It Works
Astaxanthin crosses cell membranes and positions itself across lipid bilayers, protecting both hydrophilic and lipophilic cellular components from oxidative damage. It inhibits NF-κB activation, reducing pro-inflammatory cytokine production including TNF-α and IL-6. The compound also enhances cellular antioxidant enzyme activity including superoxide dismutase and catalase.
Scientific Research
Recent meta-analyses demonstrate astaxanthin's antioxidant effects, including a 2025 analysis of 7 RCTs (PMID not provided, PROSPERO CRD420251119762) and a 2021 meta-analysis of 12 RCTs showing reduced MDA levels. Clinical trials include studies on rheumatoid arthritis (PMID: 40569081), type 2 diabetes (PMID: 33445213), coronary artery disease (PMID: 37051124), and cognitive function (PMID: 39036318).
Clinical Summary
Meta-analyses demonstrate astaxanthin's antioxidant effects, with 7 RCTs (n=188) showing significant reduction in advanced oxidation protein products (SMD = -1.06) and 12 RCTs (n=380) reducing malondialdehyde levels. One RCT (n=60) showed improvements in rheumatoid arthritis symptoms. Evidence is moderate quality but limited by small sample sizes and short study durations. Most studies used doses ranging from 4-12mg daily.
Nutritional Profile
AstaReal Astaxanthin derived from Haematococcus pluvialis microalgae is a ketocarotenoid-based ingredient with the following profile: Primary bioactive compound is astaxanthin (3,3'-dihydroxy-β,β-carotene-4,4'-dione) at typical commercial concentrations of 4–12 mg per softgel/serving in finished products, with AstaReal oleoresin extract standardized to approximately 5–10% astaxanthin by weight. The compound exists predominantly in esterified form (mono- and di-esters with fatty acids) in H. pluvialis, which enhances stability compared to free-form astaxanthin. Macronutrient content is negligible as it is delivered in small-dose encapsulated form; carrier oils (typically olive or sunflower oil) contribute minor lipid content (~0.5–1 g fat per softgel) which is intentional as astaxanthin is highly lipophilic and fat co-ingestion significantly enhances bioavailability. Micronutrients are minimal and not a primary feature. Additional carotenoids present in the algal matrix include lutein, zeaxanthin, beta-carotene, and canthaxanthin at trace levels (<1% relative to astaxanthin content). Tocopherols may be present as natural antioxidant stabilizers in the extract. Bioavailability notes: Astaxanthin absorption is highly dependent on lipid co-ingestion; bioavailability increases 3–4 fold when taken with a fat-containing meal. Esterified forms from H. pluvialis are hydrolyzed in the gut to free astaxanthin prior to absorption. AstaReal's proprietary cultivation and extraction process yields a predominantly (>95%) natural all-E (trans) isomer configuration, which is considered the most bioactive form. Plasma half-life is approximately 16–52 hours with peak plasma concentrations (Tmax) reached at 6–12 hours post-ingestion. No significant protein, fiber, or carbohydrate content is contributed by this ingredient at standard dosing.
Preparation & Dosage
Clinically studied dosage ranges: General oxidative stress/inflammation: 4-28 mg/day for 4-12 weeks. Rheumatoid arthritis: 20 mg/day for 8 weeks. Type 2 diabetes: 8 mg/day for 8 weeks. Coronary artery disease: 12 mg/day for 8 weeks. Most studies used standardized capsules from Haematococcus pluvialis. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin E, Omega-3 fatty acids, CoQ10, Vitamin C, Selenium
Safety & Interactions
AstaReal Astaxanthin is generally well-tolerated with minimal reported side effects in clinical trials. Some users may experience mild gastrointestinal upset or skin pigmentation changes at higher doses. No significant drug interactions have been documented, though theoretical interactions with anticoagulants exist due to potential anti-platelet effects. Safety during pregnancy and breastfeeding has not been established through clinical studies.